FDA & Prescription Drugs | InjuryBoard Houston

Today the watchdog group Public Citizen petitioned the U.S. government to pull the birth control patch Ortho Evra from the market. Ortho Evra has been linked to higher rates of blood clots and...

In February of this year Actavis issued a voluntary recall of 14 lots of their popular fentanyl transdermal painkilling patch. The patches are designed to treat chronic pain by slowly...

Preemption has been a big topic in the legal world over the past several months. Basically the issue is whether or not the FDA’s approval of a drug should preempt consumers from filing lawsuits for...

After hearing tearful testimony this week of the family members who recently lost loved ones treated with contaminated batches of the popular blood-thinner Heparin. Heparin was recalled in...

Yesterday the families of some of those who lost lives after being treated with a contaminated blood thinner, Heparin, told their stories to a House committee. The congressional panel listened...

Today the Actavis Totowa LLC in conjunction with the FDA issued a Class I recall of all Digitek tablets. Digitek is used to treat abnormal heart rhythms and heart failure;...

Late Friday the makers of Claritin and Singulair announced that the FDA has rejected an application for a pill combining the two drugs. Singulair, sold by Merck, is a popular medication used to...

The data is out and Pfizer’s prescription stop smoking aid Chantix was the most commonly searched medication on the Internet in the month of February. According to comScore, an Internet...

Yesterday a House panel reprimanded the FDA for their poor performance when inspecting foreign-made medications, in the aftermath of the recall of contaminated batches of the blood thinner...

Attention deficit hyperactivity disorder (ADHD) is one of the most common disorders among children. Physicians often prescribe medications to treat the symptoms of ADHD with very limited proof...

Yesterday the U.S. Supreme Court declined to hear the appeals case of a South Carolina adolescent that was sentenced to 30 years in prison without the possibility of parole, at the age of 12,...

Last fall an FDA panel unanimously voted in favor of keeping Bayer’s Trasylol on the market. The panel was convened after a New England Journal of Medicine article suggested that the drug put...

Over the past year the reports of adverse reactions to Pfizer’s smoking cessation drug Chantix have been mounting at a furious pace. After an analysis of the adverse events associated with Chantix,...

The Consumer Union advocacy group has petitioned the FDA to require television prescription drug advertisements to include a toll free number and a website address where consumers can report adverse...

According to a study published in the New England Journal of Medicine deadlines for response to new drug applications may be causing the agency to make hasty decisions. The study suggests that drugs approved closer to the deadline end up having more safety issues once on the market than drugs that are approved earlier in the process. The study shows that of the 97 drugs that were approved within...